A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

Paddington Testing Co., Inc., Philadelphia

Dermatology Consulting Services, High Point

MedaPhase, Inc., Newnan

University Clinical Research, Inc., Pembroke Pines

FXM Research, Miami

Visions Clinical Research, Boynton Beach

Tampa Bay Medical Research, Clearwater

Radiant Research, Birmingham

Dermatology Research Association, Inc., Nashville

University Dermatology Consultants, Inc., Cincinnati

Dermatology Research Associates Inc., Cincinnati

Madison Skin & Research, Inc., Madison

Dermatology Clinical Trials Unit Washington University, St Louis

Skin Specialists, PC, Omaha

J&S Studies Inc., Bryan

DermResearch, Inc., Austin

Cherry Creek Research, Inc, Denver

Radiant Research, Tucson

Academic Dermatology Associates, Albuquerque

Clincial Research Specialists, Inc., Santa Monica

Therapeutics Clinical Research, San Diego

East Bay Dermatology Medical Group, Inc., Fremont

Northwest Dermatology and Research Center, Portland

Oregon Medical Research Center, Portland

Welborn Clinic, Evansville

The Savin Center, PC, New Haven